Herpes simplex viruses (HSV) are important human pathogens that cause aggressive herpetic lesions. Although current anti-HSV drugs are effective in inhibiting HSV infections, successful treatment is complicated by the increasing prevalence of drug resistant mutants, which is becoming a clinical problem, especially in immunocompromised individuals. The development of drug-resistant mutants is a result of spontaneous mutations arising during viral replication and can be selectively amplified by anti-viral drugs. Therefore, studying the mechanism controlling the replication fidelity will lead to a better understanding of how such mutations evolve. ? HSV-1 DNA polymerase (pol) is the pivotal enzyme involved in DNA replication. It plays the central role in controlling the accuracy of DNA replication. Factors governing these steps are the Pol's identity and the sequence contexts. The former includes the structure-functional properties of the Pol. The latter includes the sequence content, the positions, orientations, and replication modes of the gene being replicated. While we demonstrated that sequence contents and replication modes (plasmid- versus genome- based replication) affect replication fidelity, the effects of a gene's position and orientation in replication fidelity have not been examined. Whereas the identity of the catalytic subunit of the Pol is an important factor in replication fidelity, it appears that the UL42 subunit of the HSV- 1 Pol complex also can affect the DNA replication fidelity. In this study we propose to examine the following aims. ? (1). Characterization of progeny derived from YD 12 exonuclease-deficient pol mutants. ? (2). Roles of UL42 accessory protein of the HSV-1 Pol in DNA replication fidelity. ? (3). Position effects of the target gene in replication fidelity. ? Results will be critical to the understanding of the molecular mechanisms regulating DNA replication fidelity of both HSV-1 and eukaryotes, and of the structure-functional relationship of HSV-1 Pol. This study also will be of value for the design of new antiviral drugs and treatments. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI056359-13
Application #
7049482
Study Section
Special Emphasis Panel (ZRG1-EVR (01))
Program Officer
Beisel, Christopher E
Project Start
1992-08-01
Project End
2009-03-31
Budget Start
2006-04-01
Budget End
2007-03-31
Support Year
13
Fiscal Year
2006
Total Cost
$296,856
Indirect Cost
Name
Upstate Medical University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
058889106
City
Syracuse
State
NY
Country
United States
Zip Code
13210
Hornstra, Heidie; Pearson, Talima; Georgia, Shalamar et al. (2009) Molecular epidemiology of glanders, Pakistan. Emerg Infect Dis 15:2036-9
Tian, Wang; Hwang, Ying T; Lu, Qiangsheng et al. (2009) Finger domain mutation affects enzyme activity, DNA replication efficiency, and fidelity of an exonuclease-deficient DNA polymerase of herpes simplex virus type 1. J Virol 83:7194-201
Jiang, Changying; Komazin-Meredith, Gloria; Tian, Wang et al. (2009) Mutations that increase DNA binding by the processivity factor of herpes simplex virus affect virus production and DNA replication fidelity. J Virol 83:7573-80
Pearson, Talima; Giffard, Philip; Beckstrom-Sternberg, Stephen et al. (2009) Phylogeographic reconstruction of a bacterial species with high levels of lateral gene transfer. BMC Biol 7:78
Drake, John W; Hwang, Charles B C (2005) On the mutation rate of herpes simplex virus type 1. Genetics 170:969-70
Randell, John C W; Komazin, Gloria; Jiang, Changying et al. (2005) Effects of substitutions of arginine residues on the basic surface of herpes simplex virus UL42 support a role for DNA binding in processive DNA synthesis. J Virol 79:12025-34